# Genmab

its DuoBody platform underpins epcoritamab (co-developed with AbbVie), reporting high response rates in elderly diffuse large B-cell lymphoma, and a broader bispecific portfolio.

Source: https://en.bioecon.ru/companies/genmab/
Updated: 2026-07-11

- Country: Denmark
- Ticker: GMAB

## Technologies

- [Bispecific & multispecific antibodies](https://en.bioecon.ru/technology/bispecific-antibodies/)